CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference bda9e581f4
Drug names50First applicant · distinct drug namesAcceptance records101First applicant · distinct acceptance numbersUnder-review numbers13First applicant · current under-review listCo-applicant records9Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/12 06:41.
Drug filings
101 acceptance records as first applicant, grouped into 50 source drug names. Source data as of 2026/11/12 06:41.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
SYH2106注射液 · No verified English name 1 records · Latest accepted 2026/11/09
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601382 | New drug | 2026/11/09 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
SYH2078注射液 · No verified English name 1 records · Latest accepted 2026/10/14
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601281 | New drug | 2026/10/14 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Ampicillin Sodium and Sulbactam Sodium for Injection 4 records · Latest accepted 2026/09/08
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650183 | Supplement | 2026/09/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2650182 | Supplement | 2026/09/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450495 | Supplement | 2024/09/25 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450494 | Supplement | 2024/09/25 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
注射用多西他赛(白蛋白结合型) · No verified English name 2 records · Latest accepted 2026/08/17
New drug · 2
利奈唑胺干混悬剂 · No verified English name 2 records · Latest accepted 2026/08/06
Generic · 2
Amphotericin B Liposome for Injection 3 records · Latest accepted 2026/06/25
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601186 | Supplement | 2026/06/25 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHS2300731 | Generic | 2023/03/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHS2101018 | Generic | 2021/03/12 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Cefcapene Pivoxil Hydrochloride Granules 1 records · Latest accepted 2026/05/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601190 | Generic | 2026/05/21 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
盐酸头孢卡品酯片 · No verified English name 1 records · Latest accepted 2026/05/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650113 | Supplement | 2026/05/12 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
阿普昔腾坦片 · No verified English name 1 records · Latest accepted 2026/01/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600013 | Generic | 2026/01/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
吸入用布地奈德混悬液 · No verified English name 1 records · Latest accepted 2026/01/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600100 | Generic | 2026/01/09 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Lansoprazole Enteric Capsules 2 records · Latest accepted 2025/12/31
Generic · 2
Mesalazine Sustained-release Granules 2 records · Latest accepted 2025/11/08
Generic · 2
盐酸米托蒽醌脂质体注射液 · No verified English name 8 records · Latest accepted 2025/09/30
Supplement · 1New drug · 7
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501951 | Supplement | 2025/09/30 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CXHL2200497 | New drug | 2022/07/12 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CXHL2200307 | New drug | 2022/05/13 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CXHL2101618 | New drug | 2021/10/29 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CXHL2101544 | New drug | 2021/10/14 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CXHL2101471 | New drug | 2021/09/13 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CXHL2101172 | New drug | 2021/06/04 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CXHL2101145 | New drug | 2021/05/25 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
SYH2070注射液 · No verified English name 1 records · Latest accepted 2025/07/17
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500709 | New drug | 2025/07/17 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.; Shi Yao Group Zhong Qi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. romanized | CDE ↗ |
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2025/04/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501393 | Generic | 2025/04/11 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Paliperidone Palmitate Injection 3 records · Latest accepted 2025/03/28
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501206 | Generic | 2025/03/28 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHS2501205 | Generic | 2025/03/28 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHS2501204 | Generic | 2025/03/28 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Budesonide Gastro-Resistant Capsules 1 records · Latest accepted 2025/03/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501113 | Generic | 2025/03/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Linaclotide Capsules 1 records · Latest accepted 2025/03/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501027 | Generic | 2025/03/12 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
阿瑞匹坦注射液 · No verified English name 3 records · Latest accepted 2025/03/03
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500896 | Generic | 2025/03/03 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHL2400077 | Generic | 2024/04/18 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHS2300273 | Generic | 2023/02/01 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
SYH2068注射液 · No verified English name 1 records · Latest accepted 2025/02/08
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500173 | New drug | 2025/02/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.; Shi Yao Group Zhong Qi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. romanized | CDE ↗ |
Ambroxol Hydrochloride Oral Solution 2 records · Latest accepted 2024/11/18
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403954 | Generic | 2024/11/18 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.; CSPC OUYI PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHS2403953 | Generic | 2024/11/18 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.; CSPC OUYI PHARMACEUTICAL CO., LTD. | CDE ↗ |
Roxadustat Capsules 4 records · Latest accepted 2024/11/01
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401775 | Supplement | 2024/11/01 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2401774 | Supplement | 2024/11/01 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHS2301419 | Generic | 2023/05/25 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHS2301418 | Generic | 2023/05/25 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
SYH2062注射液 · No verified English name 1 records · Latest accepted 2024/10/11
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401052 | New drug | 2024/10/11 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.; Shi Yao Group Zhong Qi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. romanized | CDE ↗ |
Tebipenem Pivoxil Fine Granules 1 records · Latest accepted 2024/07/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400135 | Generic | 2024/07/06 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
丁酸氯维地平注射用乳剂 · No verified English name 4 records · Latest accepted 2024/06/12
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401756 | Generic | 2024/06/12 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHS2401755 | Generic | 2024/06/12 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHL2200088 | Generic | 2022/10/13 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHL2200087 | Generic | 2022/10/13 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Tacrolimus Sustained-release Capsules 2 records · Latest accepted 2024/05/15
Generic · 2
注射用头孢唑肟钠 · No verified English name 2 records · Latest accepted 2024/04/17
Supplement · 2
Oxacillin Sodium for Injection 2 records · Latest accepted 2024/04/12
Supplement · 2
Ceftazidime for Injection 3 records · Latest accepted 2024/03/08
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450184 | Supplement | 2024/03/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450183 | Supplement | 2024/03/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450182 | Supplement | 2024/03/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Cefoperazone Sodium and Sulbactam Sodium for Injection 5 records · Latest accepted 2024/02/20
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450137 | Supplement | 2024/02/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450136 | Supplement | 2024/02/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450135 | Supplement | 2024/02/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450134 | Supplement | 2024/02/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450133 | Supplement | 2024/02/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Cefminox Sodium for Injection 2 records · Latest accepted 2024/02/20
Supplement · 2
Amoxicillin Sodium and Clavulanate Potassium for Injection 3 records · Latest accepted 2024/02/20
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450140 | Supplement | 2024/02/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450139 | Supplement | 2024/02/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2450138 | Supplement | 2024/02/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Pentoxifylline Modified Release Tablets 1 records · Latest accepted 2024/02/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400489 | Generic | 2024/02/05 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.; CSPC OUYI PHARMACEUTICAL CO., LTD. | CDE ↗ |
Meloxicam injection 1 records · Latest accepted 2024/01/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400303 | Generic | 2024/01/23 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Piperacillin Sodium for Injection 2 records · Latest accepted 2023/11/16
Supplement · 2
Tedizolid Phosphate Tablets 1 records · Latest accepted 2023/10/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302958 | Generic | 2023/10/31 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2023/10/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302914 | Generic | 2023/10/26 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Cefmetazole Sodium for Injection 3 records · Latest accepted 2023/10/10
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350751 | Supplement | 2023/10/10 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2350749 | Supplement | 2023/10/10 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2350748 | Supplement | 2023/10/10 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Ilaprazole Enteric-coated Tablets 1 records · Latest accepted 2023/10/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302674 | Generic | 2023/10/10 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Piperacillin Sodium And Tazobactam Sodium For Injection 3 records · Latest accepted 2023/09/20
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350714 | Supplement | 2023/09/20 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2250576 | Supplement | 2022/09/10 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2250575 | Supplement | 2022/09/10 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
SYH2053注射液 · No verified English name 1 records · Latest accepted 2023/09/16
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301007 | New drug | 2023/09/16 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.; Shi Yao Group Zhong Qi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. romanized | CDE ↗ |
Cefoxitin Sodium for Injection 3 records · Latest accepted 2023/04/28
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350395 | Supplement | 2023/04/28 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2350394 | Supplement | 2023/04/28 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2350393 | Supplement | 2023/04/28 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Cefuroxime Sodium for Injection 3 records · Latest accepted 2023/02/03
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350140 | Supplement | 2023/02/03 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2350139 | Supplement | 2023/02/03 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2350138 | Supplement | 2023/02/03 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Peramivir Injection 1 records · Latest accepted 2023/01/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300186 | Generic | 2023/01/19 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Ampicillin Sodium For Injection 2 records · Latest accepted 2022/11/08
Supplement · 2
注射用紫杉醇(白蛋白结合型)(II) · No verified English name 1 records · Latest accepted 2022/10/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201763 | Generic | 2022/10/18 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.; CSPC OUYI PHARMACEUTICAL CO., LTD. | CDE ↗ |
Penicillin G Sodium For Injection 3 records · Latest accepted 2022/09/02
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250558 | Supplement | 2022/09/02 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2250557 | Supplement | 2022/09/02 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| CYHB2250556 | Supplement | 2022/09/02 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Mirabegron Extended-release Tablets 1 records · Latest accepted 2022/01/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200064 | Generic | 2022/01/12 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Daunorubicin and Cytarabine liposome For Injection 1 records · Latest accepted 2021/12/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2101045 | Generic | 2021/12/02 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Amoxicillin and Clavulanate Potassium Tablets 1 records · Latest accepted 2021/10/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150946 | Supplement | 2021/10/27 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Changes in the last 90 days
6 events from 2026/08/15 to 2026/11/12. CDE data as of 2026/11/12 06:41; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 5 applicationsNo longer listed under review: 1 application
- 2026/11/11No longer listed under review
Lansoprazole Enteric Capsules
CYHS2504500
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/12/31
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/09Accepted
SYH2106注射液 · No verified English name
CXHL2601382
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ - 2026/10/14Accepted
SYH2078注射液 · No verified English name
CXHL2601281
Fact date: 2026/10/14 · Site observation date: 2026/10/22
View source ↗ - 2026/09/08Accepted
Ampicillin Sodium and Sulbactam Sodium for Injection
CYHB2650183
Fact date: 2026/09/08 · Site observation date: 2026/10/22
View source ↗ - 2026/09/08Accepted
Ampicillin Sodium and Sulbactam Sodium for Injection
CYHB2650182
Fact date: 2026/09/08 · Site observation date: 2026/10/22
View source ↗ - 2026/08/17Accepted
注射用多西他赛(白蛋白结合型) · No verified English name
CXHS2600118
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗
Under review
13 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| SYH2106注射液 · No verified English name | CXHL2601382 | New drug | 2026/11/09 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| SYH2078注射液 · No verified English name | CXHL2601281 | New drug | 2026/10/14 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | CYHB2650183 | Supplement | 2026/09/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | CYHB2650182 | Supplement | 2026/09/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| 注射用多西他赛(白蛋白结合型) · No verified English name | CXHS2600118 | New drug | 2026/08/17 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| 利奈唑胺干混悬剂 · No verified English name | CYHS2601922 | Generic | 2026/08/06 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| 注射用多西他赛(白蛋白结合型) · No verified English name | CXHS2600114 | New drug | 2026/08/04 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Amphotericin B Liposome for Injection | CYHB2601186 | Supplement | 2026/06/25 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Cefcapene Pivoxil Hydrochloride Granules | CYHS2601190 | Generic | 2026/05/21 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| 盐酸头孢卡品酯片 · No verified English name | CYHB2650113 | Supplement | 2026/05/12 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| 吸入用布地奈德混悬液 · No verified English name | CYHS2600100 | Generic | 2026/01/09 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Mesalazine Sustained-release Granules | CYHS2503907 | Generic | 2025/11/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Mesalazine Sustained-release Granules | CYHS2503906 | Generic | 2025/11/08 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
Catalogue holder records
71 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/12 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Upadacitinib Sustained-release Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20265705 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paliperidone Palmitate Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20265293 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paliperidone Palmitate Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20265294 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paliperidone Palmitate Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20265292 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Budesonide Gastro-Resistant Capsules | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Shi Yao Group Zhong Nuo Pharma (Shijiazhuang) Co., Ltd. romanized | 国药准字H20264401 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lansoprazole Enteric Capsules | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20264441 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿瑞匹坦注射液 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20263629 | 2026/03/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 氯维地平乳状注射液 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20263228 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 氯维地平乳状注射液 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20263227 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tacrolimus Sustained-release Capsules | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20255647 | 2025/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tacrolimus Sustained-release Capsules | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20255646 | 2025/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pentoxifylline Modified Release Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20255008 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 美洛昔康注射液(III) · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20254568 | 2025/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxacillin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021268 | 2025/06/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxacillin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20258102 | 2025/06/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20103666 | 2025/05/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20103719 | 2025/05/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20253827 | 2025/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ceftazidime for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20023500 | 2025/04/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20023501 | 2025/04/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20043138 | 2025/04/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20033819 | 2025/03/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20041828 | 2025/03/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20033068 | 2025/03/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20031089 | 2025/03/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20031086 | 2025/03/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Sodium and Clavulanate Potassium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20023212 | 2025/03/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Sodium and Clavulanate Potassium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20056398 | 2025/03/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Sodium and Clavulanate Potassium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20056303 | 2025/03/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefminox Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20063100 | 2025/03/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefminox Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20063101 | 2025/03/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ilaprazole Enteric-coated Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20253336 | 2025/02/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tedizolid Phosphate Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20249604 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piperacillin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021284 | 2024/10/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piperacillin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021285 | 2024/10/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefmetazole Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20163427 | 2024/10/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefmetazole Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20163426 | 2024/10/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefmetazole Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20163428 | 2024/10/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amphotericin B Liposome for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20244839 | 2024/09/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿瑞匹坦注射液 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20244783 | 2024/09/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Roxadustat Capsules | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20244185 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Roxadustat Capsules | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20244184 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefoxitin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20084296 | 2024/05/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoxitin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20247108 | 2024/05/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoxitin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20084297 | 2024/05/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Peramivir Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20243670 | 2024/05/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20247056 | 2024/03/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium For Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021266 | 2024/02/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefuroxime Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20063773 | 2024/01/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefuroxime Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20063771 | 2024/01/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefuroxime Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20063772 | 2024/01/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20045799 | 2023/10/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20045800 | 2023/10/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Mirabegron Extended-release Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20233665 | 2023/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amoxicillin and Clavulanate Potassium Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20043183 | 2022/10/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13020765 | 2021/06/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021283 | 2021/06/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 阿莫西林颗粒 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13023430 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 阿莫西林颗粒 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13024512 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20033486 | 2021/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13022881 | 2021/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20033495 | 2021/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20033494 | 2021/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021771 | 2021/01/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Dispersible Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20046510 | 2021/01/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Dispersible Tablets | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H10980075 | 2021/01/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Capsules | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021769 | 2020/01/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium For Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021267 | 2024/02/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penicillin G Sodium For Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20023706 | 2023/11/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penicillin G Sodium For Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021632 | 2023/11/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penicillin G Sodium For Injection | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H13021634 | 2023/11/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
58 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/12 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 奈玛特韦 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20250000732 | I | 2025/08/05 | CDE ↗ |
| 氟氯西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20250000581 | I | 2025/07/15 | CDE ↗ |
| 棕榈酸帕利哌酮 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20250000189 | A | 2026/07/26 | CDE ↗ |
| 磷酸西格列汀 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20250000193 | I | 2025/03/05 | CDE ↗ |
| 依托咪酯 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20240001041 | A | 2026/03/30 | CDE ↗ |
| 苯唑西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20240000449 | I | 2026/03/06 | CDE ↗ |
| 阿糖胞苷 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20240000130 | A | 2025/01/14 | CDE ↗ |
| 阿糖胞苷 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20230000059 | I | 2024/01/08 | CDE ↗ |
| 盐酸米托蒽醌 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20220001037 | A | 2024/06/27 | CDE ↗ |
| 美罗培南 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190009711 | A | 2025/08/16 | CDE ↗ |
| 头孢曲松钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190009561 | A | 2024/12/31 | CDE ↗ |
| 头孢西丁钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190008291 | A | 2023/05/05 | CDE ↗ |
| 头孢泊肟酯 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190008127 | A | 2025/07/04 | CDE ↗ |
| 头孢他啶 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190007900 | A | 2024/12/07 | CDE ↗ |
| 哌拉西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190007403 | A | 2023/09/22 | CDE ↗ |
| 氨苄西林钠 · No verified English name | Shi Yao Group Zhong Nuo Pharma (Shijiazhuang) Co., Ltd. romanized | Y20190007384 | A | 2022/10/26 | CDE ↗ |
| 厄他培南钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190007295 | A | 2024/02/02 | CDE ↗ |
| 盐酸头孢他美酯 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190007173 | A | 2023/04/08 | CDE ↗ |
| 头孢替唑钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190007168 | A | 2023/04/08 | CDE ↗ |
| 头孢硫脒 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190007084 | A | 2023/03/24 | CDE ↗ |
| 阿洛西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190007083 | A | 2023/03/24 | CDE ↗ |
| 美洛西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190007064 | A | 2023/03/24 | CDE ↗ |
| 盐酸头孢甲肟 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190006982 | A | 2023/03/24 | CDE ↗ |
| 无水碳酸钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190006966 | A | 2023/03/24 | CDE ↗ |
| 匹伐他汀钙 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190006251 | A | 2025/06/07 | CDE ↗ |
| 硫酸头孢匹罗 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190005533 | A | 2025/12/02 | CDE ↗ |
| 苄星青霉素 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190005532 | A | 2025/07/04 | CDE ↗ |
| 双氯西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190005531 | A | 2025/07/04 | CDE ↗ |
| 替卡西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190005530 | A | — | CDE ↗ |
| 头孢呋辛钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190005525 | A | 2025/07/04 | CDE ↗ |
| 头孢唑林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003412 | A | 2024/12/21 | CDE ↗ |
| 苯唑西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003410 | A | 2024/12/10 | CDE ↗ |
| 头孢噻肟钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003394 | A | 2024/12/31 | CDE ↗ |
| 氨苄西林 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003382 | A | 2024/12/10 | CDE ↗ |
| 头孢拉定 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003381 | A | 2024/12/07 | CDE ↗ |
| 盐酸头孢吡肟 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003379 | A | 2024/12/10 | CDE ↗ |
| 青霉素钾 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003362 | A | 2024/12/07 | CDE ↗ |
| 阿莫西林 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003355 | A | 2024/12/10 | CDE ↗ |
| 头孢克肟 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003349 | A | 2024/12/21 | CDE ↗ |
| 头孢克洛 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003295 | A | 2024/12/07 | CDE ↗ |
| 普鲁卡因青霉素 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003294 | A | 2024/12/07 | CDE ↗ |
| 青霉素钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003293 | A | 2024/12/21 | CDE ↗ |
| 头孢哌酮钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003292 | A | 2024/12/07 | CDE ↗ |
| 青霉素钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003291 | A | 2024/09/26 | CDE ↗ |
| 阿莫西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003290 | A | 2024/12/10 | CDE ↗ |
| 氯唑西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003284 | A | 2024/09/26 | CDE ↗ |
| 氨苄西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003283 | A | 2024/12/10 | CDE ↗ |
| 克拉维酸钾 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003282 | A | 2024/12/10 | CDE ↗ |
| 氯唑西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190003278 | A | 2024/12/07 | CDE ↗ |
| 萘夫西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190002148 | A | 2025/07/01 | CDE ↗ |
| 头孢地尼 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190001447 | A | 2024/06/14 | CDE ↗ |
| 比阿培南 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190001424 | A | 2024/06/06 | CDE ↗ |
| 头孢地嗪钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190001307 | A | 2024/02/22 | CDE ↗ |
| 头孢曲松钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20190000365 | I | 2019/05/17 | CDE ↗ |
| 盐酸度洛西汀 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20170000531 | A | 2023/03/24 | CDE ↗ |
| 氟氯西林钠 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20170000445 | I | — | CDE ↗ |
| 恩替卡韦 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20170000358 | I | — | CDE ↗ |
| 奥美沙坦酯 · No verified English name | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | Y20170000097 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
9 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| SYHX1901片 · No verified English name | CXHB2600169 | Supplement | 2026/06/05 | CSPC OUYI PHARMACEUTICAL CO., LTD.; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| SYH2053注射液 · No verified English name | CXHB2500330 | Supplement | 2025/12/16 | Shi Yao Group Zhong Qi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. romanized; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | CYHB2502383 | Supplement | 2025/11/21 | CSPC OUYI PHARMACEUTICAL CO., LTD.; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| SYH2061注射液 · No verified English name | CXHL2500812 | New drug | 2025/08/05 | Shi Yao Group Zhong Qi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. romanized; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Penicillin G Sodium For Injection | CYHB2450409 | Supplement | 2024/07/26 | Wuhan Jiu An Pharma Co., Ltd. romanized; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Penicillin G Sodium For Injection | CYHB2450408 | Supplement | 2024/07/26 | Wuhan Jiu An Pharma Co., Ltd. romanized; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2450306 | Supplement | 2024/05/31 | CSPC OUYI PHARMACEUTICAL CO., LTD.; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2450305 | Supplement | 2024/05/31 | CSPC OUYI PHARMACEUTICAL CO., LTD.; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
| 注射用紫杉醇(白蛋白结合型) · No verified English name | CYHB2101785 | Supplement | 2021/09/13 | CSPC OUYI PHARMACEUTICAL CO., LTD.; CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/12 06:41
- Chemical-drug catalogue
- Last successful update: 2026/11/12 06:38
- Full API register
- Last successful update: 2026/11/12 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.